Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Joe Krupa who wrote (13272)	1/26/2004 11:20:35 PM
From: Salt'n'Peppa	Respond to of 14101

My thoughts exactly Joe. While I think Pennsaid is a great product (and have crystallized about $15K in losses on DMX believing in the drug), this is exactly why I sold the last of my shares last week at just over $1. I may consider buying back after the next round of financing, WHEN it drops below 75 cents. I have a lot of $$$ to make back with this one. Cheers, S&P

To: Joe Krupa who wrote (13272)	1/27/2004 2:58:15 PM
From: Joe Krupa	Read Replies (3) \| Respond to of 14101

Acqua Wellington: More to this than I realized! I posted over the past few days how the current financing arrangement with Paradigm, is, in effect, just another version of the former Acqua Wellington arrangement (ie. just another death spiral, equity line-of-credit). I made this comparison by pointing out the similar modus operandi of both financing forms as they related to Dimethaid. For those who are not aware, Dimethaid was forced to terminate their former financing arrangement with Acqua Wellington when the TSE banned equity line-of-credits on their market. Well, there was more truth to the analogy than originally met the eye. Paradigm capital is really just the old Acqua wolf in sheep's clothing. Consider the following: Thursday October 30, 4:01 pm ET TORONTO, Oct. 30 /CNW/ - Pharmaceutical developer Dimethaid Research Inc. (TSX: DMX - News) is pleased to announce that it has successfully completed the previously announced private placement of 14,377,688 special warrants. The offering was led by Paradigm Capital Inc. and included Vengate Capital Partners Company. biz.yahoo.com Who is Vengate Capital Parnters? TORONTO/NEW YORK, June 14, 2001 /PRNewswire/ MDS Capital Corp. of Toronto and Acqua Wellington Asset Management of New York announce the formation of a new joint venture called Vengate Capital Partners. corporate-ir.net So, Acqua Wellington really is participating in the latest round of financing through it's subsidiary Vengate capital. Rebecca has circumvented the TSE regulations by playing with it's offspring, Vengate. There's your new "traditional financing" folks. Do you want more of this? If so, just sit back and watch your money vanish. Are you fed up and want change? Then private message Tim Barnes (aka "Barneytalks" on Stockhouse) and indicate your level of interest in offering your proxies should the situation arise where they may be needed. Your proxies are not needed or wanted at this point, but rather the expression of interest is what is necessary now. joe